Here’s a pretty deep-dive on the differences and what it actually means for those of us on the frontlines of medical device cybersecurity.

“How does Canada compare to other countries on medical device cybersecurity regulation?” It’s a reasonable question, and the honest answer is the comparison is a bit uncomfortable. Particularly when you look at what the European Union has put in place under NIS2 and compare it to where Canada actually is today — not where we aspire to be, but where the law actually stands.

The EU’s NIS2 Directive has been in force since October 2024 and healthcare is explicitly in scope. Hospital boards are personally accountable and fines can be up to €10 million. Canada, meanwhile, still has no enacted critical infrastructure cybersecurity legislation — and healthcare isn’t even in the bill that’s currently before Parliament. Here’s what that gap means for Biomed or HTM professionals managing connected devices on a clinical network.

This post breaks down both frameworks, compares them directly, and identifies the specific gaps that matter most at the device level in a healthcare facility. We’ll try to keep the regulatory language to a minimum and focus on what this means in practice for the people actually managing these devices.

The European Framework: NIS2 Is Live and Healthcare Is In It

The EU’s Network and Information Security Directive 2 (Directive (EU) 2022/2555) — universally known as NIS2 — came into force in January 2023 and became enforceable across all EU Member States from October 18, 2024.^[1] This is not a proposal or a consultation document. It is in force now.

Healthcare is explicitly named in Annex I as an essential entity sector, covering hospitals and healthcare providers, EU reference laboratories, pharmaceutical manufacturers, and — critically for our purposes — manufacturers of medical devices and in vitro diagnostic devices. Smaller entities and medical device manufacturers at lower risk thresholds fall under the “important entity” category, but they still carry full NIS2 obligations.^[2]

What NIS2 Actually Requires

The obligations are concrete and operational. Under Article 21 of the Directive, covered entities must implement technical, operational, and organisational cybersecurity risk management measures. For healthcare organisations, this translates to:^[3]

• Multi-factor authentication (mandatory where feasible)
• Data encryption at rest and in transit, with regularly tested backups
• Deployed firewalls and intrusion detection systems
• Documented incident response procedures, tested through tabletop exercises
• Formal evaluation of third-party and supply chain cybersecurity — with audit rights and mandatory contract clauses
• Regular cybersecurity training for management and staff

Incident reporting follows a three-stage structure: a 24-hour early warning, a 72-hour initial notification to the national authority, and a one-month final report.^[1] There is no ambiguity about timing and no discretion about whether to report a significant incident.

Perhaps the most structurally significant change is executive accountability. NIS2 places personal liability on hospital management and boards of directors for implementing and overseeing cybersecurity measures — and gives supervisory authorities the power to suspend management functions pending remediation. Cybersecurity is no longer an IT department problem in an EU healthcare organisation. It is a board-level obligation.^[3]

Enforcement is real: fines of up to €10 million or 2% of global annual turnover for essential entities, whichever is higher. Supervisory authorities also have power to issue binding instructions and disclose non-compliance publicly.^[2]

Worth noting

In January 2026, the European Commission proposed targeted amendments to NIS2 to increase legal clarity and reduce complexity for smaller organisations. The fact that the EU is actively refining and improving a framework that has been in force for over a year — rather than still trying to pass foundational legislation — illustrates the distance between the two regulatory environments.

The Canadian Framework: Guidance Without Obligation

Canada’s situation is more fragmented, and being direct about it: there is no enacted cybersecurity legislation that applies to healthcare delivery organisations in Canada today (we’ll discuss why that is later in the post).

What Does Exist

The foundational cyber-relevant regulation for medical devices remains the Food and Drugs Act and the Medical Devices Regulations, interpreted through Health Canada’s 2019 Guidance Document: Pre-market Requirements for Medical Device Cybersecurity.^[4] This document makes clear that Health Canada considers cybersecurity a component of device design and lifecycle that can affect patient safety — and it places substantive obligations on manufacturers to demonstrate cybersecurity controls at the pre-market stage.

That is genuinely important. But the critical word is “pre-market.” The guidance creates obligations for what a manufacturer must demonstrate before a device is licensed. It does not create post-market enforcement obligations for healthcare delivery organisations. It does not tell a hospital what it must do with a fleet of networked infusion pumps once they are deployed. The healthcare organisation’s obligation under this framework is essentially to operate devices within the manufacturer’s validated configuration.

Privacy law — PIPEDA federally and provincial equivalents in British Columbia, Alberta, and Quebec (Law 25) — creates breach notification obligations when personal health information is exposed. These are data-centric, not operational. They concern what happens after a breach, not how a security program must be structured before one.

The Canadian Centre for Cyber Security’s ITSAP.00.132 (Cyber Security for Connected Medical Devices)^[5] provides good, practical guidance for healthcare organisations and device manufacturers — including a shared responsibility model that aligns well with Health Canada’s framing. But CCCS guidance is advisory. There is no enforcement mechanism, no reporting obligation, no fine for ignoring it.

The Legislative Picture: Bill C-8 Is in Progress, Healthcare Is Not In It

Canada’s primary vehicle for critical infrastructure cybersecurity legislation has had a difficult journey. Bill C-26, which would have enacted the Critical Cyber Systems Protection Act (CCSPA), was introduced in June 2022, made it to third reading in the Senate, and then died on the Order Paper when Parliament was prorogued in January 2025.^[6]

A substantially similar bill — Bill C-8 — was tabled on June 18, 2025.^[7] As of early 2026, it has passed second reading and entered committee study in the Standing Committee on Public Safety and National Security.^[8] The bill is expected to pass, given its near-identical predecessor nearly made it through the previous Parliament.

But here is the part that matters for healthcare: healthcare is not in Bill C-8’s initial scope. The sectors initially designated as “vital” under the proposed CCSPA are telecommunications, interprovincial pipelines and power lines, nuclear energy, transportation, banking, and financial clearing systems.^[9] Healthcare could be added by Governor in Council order, and it has been identified as a potential future sector — but that requires a separate regulatory step after the legislation passes.

Status as of March 2026

Bill C-8 is in committee study. It covers telecom, energy, finance, and transport. Healthcare is not designated. Even if the bill passes this year, a further regulatory order is needed before any mandatory cybersecurity obligations apply to Canadian healthcare delivery organisations under this framework.

Side-by-Side Comparison

Dimension	EU / NIS2	Canada (current)
Legislative status	In force since Oct 2024	Bill C-8 in committee; no enacted law
Healthcare sector in scope	Yes — essential entity (Annex I)	No — not designated in Bill C-8
Medical device manufacturers in scope	Yes — important entity (Annex II)	Pre-market only (Health Canada 2019 guidance)
Mandatory incident reporting for healthcare	Yes — 24hr / 72hr / 30-day tiered	No — voluntary only (CCCS)
Minimum security controls mandated	Yes — MFA, encryption, IDS, backups, BCP	Advisory only (CCCS guidance)
Supply chain / vendor security obligations	Mandatory — audit rights, contract clauses	Advisory only
Board / executive personal accountability	Yes — personal liability, management suspension power	None for cybersecurity outcomes
Enforcement and fines	Up to €10M / 2% global turnover	None applicable to healthcare currently
Staff training mandate	Required (management + staff)	Not mandated
National coordination body	ENISA + national CSIRTs (enforcement powers)	CCCS (advisory role only)
Post-market device security obligations	NIS2 + EU MDR create overlapping post-market accountability	No post-market enforcement mechanism

Why Canada’s Gap Is Harder to Close Than It Looks

Looking at that comparison table, the obvious question is: why hasn’t Canada simply done what the EU did? The honest answer has 2 parts:

• Canada’s constitutional structure makes a NIS2-equivalent framework for healthcare genuinely difficult — not impossible, but considerably more complicated than passing a single piece of federal legislation.
• Need for policy and regulatory alignment with our southern neighbor – the U.S. represents a market 10x that of Canada and therefore it is likely deemed unreasonable to expect manufacturers to meet unique regulatory requirements for a small marketplace (though we could try to emulate the EU as manufacturers are having to comply with NIS2–just sayin’)

Health is not explicitly assigned in the Constitution Act, 1867. Through more than 150 years of legislation and court decisions, the delivery of healthcare has been placed primarily under provincial jurisdiction — through provincial powers over hospitals, property and civil rights, and matters of a local nature. Hospitals are provincial institutions. Health authorities are provincial bodies. The networks that connected medical devices run on are managed by provincial entities. The federal government cannot simply legislate cybersecurity standards for a regional health authority in British Columbia the way it can regulate a national telecommunications carrier — the constitutional footing is completely different.

This is why Bill C-8 looks the way it does. The sectors it designates as “vital” — telecommunications, interprovincial pipelines, nuclear energy, banking, transportation — are all areas of federal constitutional jurisdiction. The federal government can mandate cybersecurity for Bell Canada because it regulates telecommunications. It can mandate cybersecurity for TD Bank because banking is explicitly a federal power under section 91 of the Constitution. Healthcare doesn’t fit this pattern cleanly, and any attempt to directly regulate provincial hospital cybersecurity programs would face immediate constitutional challenge — and would likely not survive it.

The structural problem in plain terms

The federal government regulates medical device manufacturers through the Food and Drugs Act — and does so through Health Canada’s pre-market guidance. But regulating the healthcare operator — the hospital that deploys and manages those devices on a clinical network — is a provincial matter. The provinces have the authority to act, but most haven’t moved meaningfully. Ottawa has tools available (the spending power attached to health transfers, for example) but using them aggressively reignites perennial federal-provincial tensions over health funding and jurisdiction. The result is a gap at precisely the intersection where device-level cybersecurity risk actually lives: the post-deployment, operational environment inside a healthcare facility.

This is not a uniquely Canadian problem — federal states everywhere wrestle with divided jurisdiction over healthcare. What makes Canada’s situation particularly acute is that neither level of government has moved decisively, so the constitutional complexity has functioned as a convenient excuse for inaction at both levels simultaneously.

The provinces are not completely standing still, but progress is uneven. British Columbia is arguably furthest ahead — the BC Auditor General’s 2023 report on PHSA’s medical device cybersecurity management identified significant deficiencies and created a meaningful public accountability mechanism even without specific legislation. Ontario’s Personal Health Information Protection Act and Quebec’s Law 25 (fully in force since September 2023) create substantive data security obligations — but both are framed around protecting personal health information rather than mandating operational cybersecurity programs or device management standards. No Canadian province has enacted an operational healthcare cybersecurity framework comparable to NIS2. Not one.

The EU solved the analogous multi-jurisdictional problem by being clear about what is a European competency (internal market integrity, network security) versus what remains national (health system organisation). The EU Medical Devices Regulation governs manufacturers uniformly across all member states; NIS2 governs operators. Both instruments come from the same legislative body and are designed to create overlapping, mutually reinforcing obligations at both ends of the device lifecycle. Canada’s federal-provincial dynamic is more contentious than the EU’s member-state relationships in this domain, but the underlying approach — find the right constitutional hook at each level and build outward from there — is the same framework that would need to work here.

The most constitutionally robust path forward in Canada probably involves a pan-Canadian framework negotiated through health ministers or the Council of the Federation — where provinces agree to common cybersecurity standards for healthcare delivery as voluntary commitments aligned with federal funding conditions, rather than direct federal mandates. Slower than NIS2’s approach, more politically complex, and requiring simultaneous will from multiple governments. But it works within Canada’s constitutional reality rather than against it.

The important distinction

The gaps identified in the comparison table above are real — Canadian healthcare delivery organisations operate without the mandatory cybersecurity obligations their EU counterparts now face. But those gaps are not simply the result of indifference or inaction. They reflect a genuine constitutional structure that requires a more complex solution than passing a single federal law. Understanding this matters for anyone working to advocate for change: the right ask is not just “Ottawa should do what Brussels did,” but rather “how do we build a framework that works within Canada’s federal-provincial architecture while still producing meaningful, enforceable outcomes for patient safety?” That is a harder question, and it deserves a more sophisticated answer than the comparison table alone suggests.

What This Means at the Device Level

This is where the regulatory gap becomes most tangible. Let’s walk through a concrete scenario: a biomedical department managing a fleet of networked infusion pumps.

In an EU hospital under NIS2, HTM operates within a framework where the hospital has legally mandated obligations to assess whether those devices are part of a critical cyber system, evaluate the pump manufacturer’s cybersecurity posture as part of contractual supply chain obligations, maintain a formal device-inclusive incident response plan tested through exercises, and report significant incidents within 24 hours. The board is personally accountable. An external auditor can inspect. Non-compliance has financial consequences.

In a Canadian hospital today, the same HTM department operates in a framework where Health Canada’s guidance creates obligations for the manufacturer — but no post-market enforcement mechanism for the hospital. Provincial privacy law triggers notification if patient data is exposed, but says nothing about how the security program itself must be structured. CCCS guidance recommends good practices with no teeth. Accreditation Canada’s Qmentum program is beginning to ask cybersecurity questions, but has no specific medical device security standard. There is no mandatory incident reporting timeline, no mandated board accountability, and no prescribed minimum controls.

The practical result is that a Canadian HTM team has substantial freedom to do cybersecurity well — and almost no regulatory compulsion to do so. The motivation is patient safety and institutional risk management. In the EU, both motivations now apply simultaneously.

Canada’s Specific Gaps Relative to NIS2

• No healthcare sector designation. Bill C-8 covers telecom, finance, energy, and transport. Healthcare requires a separate Governor in Council order after the legislation passes — which adds months or years to the timeline even after the bill becomes law.
• No mandatory incident reporting framework for healthcare. NIS2’s tiered 24-hour/72-hour/30-day structure has no Canadian equivalent for healthcare delivery organisations. The CCCS voluntary reporting mechanism exists but carries no obligation.
• No mandated minimum security controls. NIS2 specifies MFA, encryption, IDS/IPS, backup testing, and business continuity planning as baseline requirements. Canadian healthcare has no equivalent mandatory baseline — CCCS and NIST CSF are recommended, not required.
• No supply chain and vendor security obligations. NIS2 Article 21(2)(d) makes vendor security assessment legally mandatory, including audit rights and contractual incident notification requirements. A Canadian hospital can procure a networked medical device that discloses Windows XP and no authentication on its MDS2 form and face no regulatory consequence for deploying it without compensating controls.
• No executive or board accountability. NIS2’s personal liability provisions for management and the power to suspend management functions for non-compliance have no equivalent in Canadian healthcare governance. There is no personal consequence for a hospital executive whose organisation’s cybersecurity program is inadequate.
• No post-market enforcement for medical device cybersecurity. Health Canada’s guidance is pre-market focused. There is no mechanism to compel a manufacturer to issue a patch for a post-market vulnerability, or to penalise a healthcare organisation for operating a device outside its validated configuration. The EU’s combination of NIS2 and the EU Medical Devices Regulation creates overlapping post-market accountability that Canada lacks.
• No enforcement-backed national coordination for healthcare. CCCS is a capable and well-regarded organisation, but its mandate is advisory. There is no healthcare-specific information sharing and analysis centre mandated by law, and no cross-provincial coordination mechanism comparable to the EU’s CyCLONe network for managing large-scale healthcare cyber incidents.

The Uncomfortable Summary

Canada’s regulatory posture on healthcare cybersecurity in 2026 resembles where the EU was under the original NIS Directive circa 2018 — guidance-forward, enforcement-light, with healthcare nominally in scope for future legislative attention but without specific operational obligations at the facility level.

The EU, through NIS2, has moved decisively to a compliance-and-enforcement model with personal board accountability, mandated minimum controls, structured incident reporting, supply chain obligations, and meaningful financial penalties. It is an imperfect framework — the January 2026 amendments signal that — but it is an operational framework with real consequences for non-compliance.

For Canadian HTM and Biomed professionals, We think this comparison matters in two directions. First, it argues for doing the right thing proactively. The regulatory direction is clear even if the compulsion isn’t here yet. Bill C-8 will pass. Healthcare will eventually be designated. The organisations that are already building structured programs, documenting their device inventories, maintaining vendor cybersecurity assessments, and testing their incident response plans will not be scrambling when that day comes.

Second, this gap is worth surfacing publicly. Canadian healthcare delivery organisations are managing device-level cyber risk in a regulatory vacuum that their EU counterparts no longer inhabit. That asymmetry has patient safety implications that should be part of the national conversation about what Bill C-8 looks like when it includes healthcare — not an afterthought to it.

What to watch

The critical next event for Canadian healthcare cybersecurity is the passage of Bill C-8 and the subsequent Governor in Council designation process. If you want to stay current on both the Canadian regulatory landscape and its international context, the cy4med.ca blog covers Canadian healthcare cyber developments as they happen — including a regularly updated Canadian healthcare cybersecurity news roundup.

References and Further Reading

1. Directive (EU) 2022/2555 of the European Parliament and of the Council — NIS2 Directive, Official Text. EUR-Lex. December 2022.
2. NIS2 Compliance Guide: Requirements and Readiness. Hyperproof. January 2026. (Overview of essential vs. important entity obligations and enforcement provisions.)
3. The NIS2 Directive — Articles and Commentary. NIS-2-Directive.com. (Plain-language reference covering Article 21 risk management requirements and incident reporting timelines.)
4. Guidance Document: Pre-market Requirements for Medical Device Cybersecurity. Health Canada. June 2019.
5. Cyber Security for Connected Medical Devices (ITSAP.00.132). Canadian Centre for Cyber Security.
6. Bill C-8 Reboots Canada’s Cybersecurity Legislation. Fasken. October 2025. (Summary of Bill C-26 history and Bill C-8 reintroduction.)
7. Bill C-8 (45-1) — LEGISinfo. Parliament of Canada. Tabled June 18, 2025.
8. From Bill C-26 to C-8: Canada’s Cyber Law Reboot Explained. Security Brief Canada. March 2026. (Current legislative status and committee study timeline.)
9. Charter Statement — Bill C-8. Department of Justice Canada. September 2025. (Definitive description of CCSPA scope and designated vital services.)
10. Bill C-8 Revives Canadian Cyber Security Reform. Borden Ladner Gervais. July 2025. (Analysis of CCSPA obligations and penalty regime.)
11. Guidance Document: Software as a Medical Device (SaMD) — Definition and Classification. Health Canada. 2019.
12. Food and Drugs Act. Government of Canada.
13. Medical Devices Regulations (SOR/98-282). Government of Canada.
14. IEC 80001-1:2021 — Application of Risk Management for IT-Networks Incorporating Medical Devices. ISO.